Literature DB >> 16728219

Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era.

Mehdi H Shishehbor1, Eric J Topol, Debabrata Mukherjee, Tingfei Hu, David J Cohen, Gregg W Stone, Rick McClure, Marco Roffi, David J Moliterno.   

Abstract

Clinical outcomes after multivessel versus single-vessel percutaneous coronary intervention (PCI) in the era of stents, glycoprotein IIb/IIIa inhibitors, and clopidogrel pretreatment have not been well studied. Thus, we compared outcomes from the Do Tirofiban and ReoPro Give Similar Efficacy Outcome Trial (TARGET) for patients who underwent multivessel versus single-vessel PCI and separately considered the effect of acute coronary syndromes on the results. Composite clinical outcomes (death, myocardial infarction, and target vessel revascularization) were evaluated at 30 days and 6 months and mortality at 1 year. Safety analysis included in-patient major and minor bleeding. Despite similar baseline characteristics, patients who underwent multivessel PCI (n = 775) had significantly higher 30-day and 6-month composite event rates than did those who were treated in a single coronary artery territory (n = 3,969). This association remained significant at 30 days (hazard ratio 1.57, 95% confidence interval 1.06 to 2.33, p = 0.025) after using propensity matching to minimize confounding factors. The higher event rate was primarily due to an increase in periprocedural myocardial infarction. However, there were no significant differences in propensity-matched ischemic outcomes at 6 months and 1 year or in bleeding. In addition, in a propensity-matched analysis that included 810 patients with acute coronary syndrome, multivessel stenting resulted in numerically more ischemic events than did single-vessel stenting, although this did not reach statistical significance (hazard ratio 1.32, 95% confidence interval 0.85 to 2.05, p = 0.221). In conclusion, multivessel PCI was more often associated with periprocedural myocardial infarction than single-vessel intervention, although this did not translate into higher 1-year mortality. A randomized trial comparing multivessel PCI with staged or surgical revascularization is warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728219     DOI: 10.1016/j.amjcard.2005.12.049

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry.

Authors:  Timm Bauer; Helge Möllmann; Uwe Zeymer; Matthias Hochadel; Holger Nef; Franz Weidinger; Ralf Zahn; Christian W Hamm; Jean Marco; Anselm K Gitt
Journal:  Heart Vessels       Date:  2011-11-09       Impact factor: 2.037

2.  Treating patients with non-STEMI: stent the culprit artery only or address all lesions?

Authors:  Mehdi H Shishehbor; Deepak L Bhatt
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-02

3.  Prognostic value of positive T wave in lead aVR in patients with non-ST segment myocardial infarction.

Authors:  Ahmad Separham; Bahram Sohrabi; Arezou Tajlil; Leili Pourafkari; Robabeh Sadeghi; Samad Ghaffari; Nader D Nader
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-04-19       Impact factor: 1.468

4.  Troponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary intervention.

Authors:  M B Nienhuis; J P Ottervanger; J-H E Dambrink; L D Dikkeschei; H Suryapranata; A W J van 't Hof; J C A Hoorntje; M J de Boer; A T M Gosselink; F Zijlstra
Journal:  Neth Heart J       Date:  2007-05       Impact factor: 2.380

5.  Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis.

Authors:  Hyun Su Jo; Jong Seon Park; Jang Won Sohn; Joon Cheol Yoon; Chang Woo Sohn; Sang Hee Lee; Geu Ru Hong; Dong Gu Shin; Young Jo Kim; Myung Ho Jeong; Shung Chull Chae; Seung Ho Hur; Taek Jong Hong; In Whan Seong; Jei Keon Chae; Jay Young Rhew; In Ho Chae; Myeong Chan Cho; Jang Ho Bae; Seung Woon Rha; Chong Jin Kim; Dong Hoon Choi; Yang Soo Jang; Jung Han Yoon; Wook Sung Chung; Ki Bae Seung; Seung Jung Park
Journal:  Korean Circ J       Date:  2011-12-31       Impact factor: 3.243

Review 6.  Multivessel versus Single Vessel Angioplasty in Non-ST Elevation Acute Coronary Syndromes: A Systematic Review and Metaanalysis.

Authors:  Javier Mariani; Alejandro Macchia; Maximiliano De Abreu; Gabriel Gonzalez Villa Monte; Carlos Tajer
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.